HEADER VIRAL PROTEIN 10-JAN-21 7LC8 TITLE SARS-COV-2 SPIKE PROTEIN TM DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S2'; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: TM DOMAIN, RESIDUES 1217-1237; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CORONAVIRUS, SARS, COVID 19, SEVERE ACUTE RESPIRATORY SYNDROME KEYWDS 2 CORONAVIRUS 2, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 14 AUTHOR Q.FU,J.J.CHOU REVDAT 4 15-MAY-24 7LC8 1 REMARK REVDAT 3 14-JUN-23 7LC8 1 REMARK REVDAT 2 14-JUL-21 7LC8 1 JRNL REVDAT 1 23-JUN-21 7LC8 0 JRNL AUTH Q.FU,J.J.CHOU JRNL TITL A TRIMERIC HYDROPHOBIC ZIPPER MEDIATES THE INTRAMEMBRANE JRNL TITL 2 ASSEMBLY OF SARS-COV-2 SPIKE. JRNL REF J.AM.CHEM.SOC. V. 143 8543 2021 JRNL REFN ESSN 1520-5126 JRNL PMID 34086443 JRNL DOI 10.1021/JACS.1C02394 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.48 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LC8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000254069. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 55 MM [U-99% 2H] 1,2-DIMYRISTOYL REMARK 210 -SN-GLYCERO-3-PHOSPHOCHOLINE, 100 MM [U-99% 2H] 1,2-DIHEXANOYL- REMARK 210 SN-GLYCERO-3-PHOSPHOCHOLINE, 20 MM TRIS, 0.02 % SODIUM AZIDE, 20 REMARK 210 MM SODIUM CHLORIDE, 1 MM [U-13C; U-15N] SPIKE GLYCOPROTEIN, 90% REMARK 210 H2O/10% D2O; 55 MM [U-99% 2H] 1,2-DIMYRISTOYL-SN-GLYCERO-3- REMARK 210 PHOSPHOCHOLINE, 100 MM [U-99% 2H] 1,2-DIHEXANOYL-SN-GLYCERO-3- REMARK 210 PHOSPHOCHOLINE, 20 MM TRIS, 0.02 % SODIUM AZIDE, 20 MM SODIUM REMARK 210 CHLORIDE, 1 MM [U-13C; U-15N; U-2H] SPIKE GLYCOPROTEIN, 90% H2O/ REMARK 210 10% D2O; 55 MM 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 100 REMARK 210 MM 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 20 MM TRIS, 0.02 % REMARK 210 SODIUM AZIDE, 20 MM SODIUM CHLORIDE, 1 MM [U-15N; U-2H] SPIKE REMARK 210 GLYCOPROTEIN, 90% H2O/10% D2O; 55 MM 1,2-DIMYRISTOYL-SN-GLYCERO- REMARK 210 3-PHOSPHOCHOLINE, 100 MM 1,2-DIHEXANOYL-SN-GLYCERO-3- REMARK 210 PHOSPHOCHOLINE, 20 MM TRIS, 0.02 % SODIUM AZIDE, 20 MM SODIUM REMARK 210 CHLORIDE, 1 MM [U-13C; U-15N; U-2H] SPIKE GLYCOPROTEIN, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HNCO; 3D 1H-15N NOESY; 2D 1H-15N REMARK 210 HSQC NH2 ONLY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR NIH 2.48, XEASY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 14 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30842 RELATED DB: BMRB REMARK 900 SARS-COV-2 SPIKE PROTEIN TM DOMAIN DBREF 7LC8 A 1217 1237 UNP P0DTC2 SPIKE_SARS2 1217 1237 DBREF 7LC8 B 1217 1237 UNP P0DTC2 SPIKE_SARS2 1217 1237 DBREF 7LC8 C 1217 1237 UNP P0DTC2 SPIKE_SARS2 1217 1237 SEQADV 7LC8 LEU A 1229 UNP P0DTC2 MET 1229 ENGINEERED MUTATION SEQADV 7LC8 LEU A 1233 UNP P0DTC2 MET 1233 ENGINEERED MUTATION SEQADV 7LC8 SER A 1235 UNP P0DTC2 CYS 1235 CONFLICT SEQADV 7LC8 SER A 1236 UNP P0DTC2 CYS 1236 CONFLICT SEQADV 7LC8 THR A 1237 UNP P0DTC2 MET 1237 CONFLICT SEQADV 7LC8 LEU B 1229 UNP P0DTC2 MET 1229 ENGINEERED MUTATION SEQADV 7LC8 LEU B 1233 UNP P0DTC2 MET 1233 ENGINEERED MUTATION SEQADV 7LC8 SER B 1235 UNP P0DTC2 CYS 1235 CONFLICT SEQADV 7LC8 SER B 1236 UNP P0DTC2 CYS 1236 CONFLICT SEQADV 7LC8 THR B 1237 UNP P0DTC2 MET 1237 CONFLICT SEQADV 7LC8 LEU C 1229 UNP P0DTC2 MET 1229 ENGINEERED MUTATION SEQADV 7LC8 LEU C 1233 UNP P0DTC2 MET 1233 ENGINEERED MUTATION SEQADV 7LC8 SER C 1235 UNP P0DTC2 CYS 1235 CONFLICT SEQADV 7LC8 SER C 1236 UNP P0DTC2 CYS 1236 CONFLICT SEQADV 7LC8 THR C 1237 UNP P0DTC2 MET 1237 CONFLICT SEQRES 1 A 21 TRP LEU GLY PHE ILE ALA GLY LEU ILE ALA ILE VAL LEU SEQRES 2 A 21 VAL THR ILE LEU LEU SER SER THR SEQRES 1 B 21 TRP LEU GLY PHE ILE ALA GLY LEU ILE ALA ILE VAL LEU SEQRES 2 B 21 VAL THR ILE LEU LEU SER SER THR SEQRES 1 C 21 TRP LEU GLY PHE ILE ALA GLY LEU ILE ALA ILE VAL LEU SEQRES 2 C 21 VAL THR ILE LEU LEU SER SER THR HELIX 1 AA1 TRP A 1217 THR A 1237 1 21 HELIX 2 AA2 LEU B 1218 SER B 1236 1 19 HELIX 3 AA3 LEU C 1218 THR C 1237 1 20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1